Home › Upcoming votes › ANAVEX LIFE SCIENCES CORP.
This meeting took place on September 24, 2026. ANAVEX LIFE SCIENCES CORP. reported the official results on Form 8-K, filed September 28, 2026 (read it on EDGAR); they are listed below. How funds voted appears on the company page after funds file Form N-PX, by August 31 after the proxy season ends on June 30.
Read the proxy statement on EDGARANAVEX LIFE SCIENCES CORP.: past votes
Ballot: see the proxy statement. The items on this ballot could not be read from the filing with enough confidence to list them here. Read the proxy statement. This is a contested meeting: the board and the other side each send their own proxy card, and both proxy statements are listed below.
From ANAVEX LIFE SCIENCES CORP.’s Form 8-K, filed June 13, 2025, for the meeting held June 10, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Christopher Missling, PhD | 93% | — |
| Elect Director: Jiong Ma, PhD | 96% | — |
| Elect Director: Claus van der Velden, PhD | 88% | — |
| Elect Director: Athanasios Skarpelos | 96% | — |
| Elect Director: Steffen Thomas, PhD | 93% | — |
| Elect Director: Peter Donhauser, D.O. | 93% | — |
| 2. The stockholders holding a majority of the Common Stock having voting power present in person or represented by proxy ratified Grant Thor | 96% | — |
| 3. The approval of an amendment to the Company's 2022 Omnibus Incentive Plan | 77% | Approved |
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Jiong Ma, Ph.D. | 72% | — |
| Elect Director: Peter Donhauser, D.O. | 85% | — |
| Elect Director: Axel Paeger, M.D., MBA, MBI | 89% | — |
| Elect Director: Gautam Patel, MBA | 88% | — |
| Elect Director: Adrian Senderowicz, M.D. | 90% | — |
| Elect Director: Claus van der Velden, Ph.D. | 78% | — |
| Elect Director: Patrick S. Adams | 22% | — |
| Elect Director: John Boris | 22% | — |
| Elect Director: Dale Curtis Hogue, Jr. | 34% | — |
| Elect Director: Jason Kolbert | 41% | — |
| Elect Director: Rene Mora, M.D., Ph.D. | 24% | — |
| Elect Director: Ralf von Ziegesar | 18% | — |
| 2. The stockholders holding a majority of the Common Stock having voting power present in person or represented by proxy ratified Grant Thor | 94% | — |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.